Matthew T. Wiley
Chief Commercial Officer
Chief Commercial Officer at Definium Therapeutics, Inc., filing insider transactions on 2026-06-25.
Total Purchases
—
0 transactions
Total Sales
$129K
1 transaction
Companies Traded
1
1 total filings
Active Since
2026-06-25
Last: 2026-06-25
Other Reporting Insiders at Definium Therapeutics, Inc.
Transaction History
| Date | Ticker | Type | Shares | Price | Value | Owned After | |
|---|
| 2026-06-25 | DFTX | Sale | 2,867 | $45.03 | $129K | 174.6K | SEC ↗ |
Director & Chief Executive Officer